Atea Pharmaceuticals, Inc. (AVIR) Stock buybacks 2024–2025
Atea Pharmaceuticals, Inc. (AVIR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$25.5MFY2025 · since FY2024: $0 → $25.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.5M | — |
| FY2024 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice